Search ARM

We support the development of safe and effective regenerative medicines and advanced therapies worldwide.

The Alliance for Regenerative Medicine (ARM) is an international community of small and large companies, non-profit research institutions, patient organizations, and other sector stakeholders dedicated to realizing the promise of regenerative medicine for patients around the world.

Join ARM at Our Next Event

ARM’s events bring together industry leaders, investors, policy makers, clinicians, and patients to network, partner, and learn about the latest clinical and commercial successes and challenges facing the sector.

ALL EVENTS

January
13
2020

Cell & Gene Therapies State of the Industry Briefing

Location: 55 Cyril Magnin St. San Francisco, CA 94102

Join ARM for the 10th Annual Cell & Gene Therapies State of the Industry Briefing, a top-level gathering for key stakeholders in the field. This event will include ARM’s annual yearly update on the sector’s progress, as well as two panels featuring top CEOs and executives highlighting future inflection points for cell and gene therapies in 2020.

Find Out More
The Latest
ARM, Intellia Therapeutics, and CRISPR Therapeutics released co-sponsored report, “The Future of Therapeutic Genome Editing in European Healthcare Systems,” providing an overview of the clinical, commercial, regulatory, and bioethical landscape for gene editing in Europe, endorsed by former MEP Maria Teresa Giménez Barbat of Spain.

View Report

Learn About Regenerative Medicine

Regenerative medicine includes gene therapies, cell therapies, and tissue-engineered products intended to augment, repair, replace, or regenerate organs, tissues, cells, genes, and metabolic processes in the body.

Regenerative medicine aims to alter the current practice of medicine by treating the root causes of disease and disorders.

 

Discover the Alliance

ARM takes the lead on the most important issues facing the regenerative medicine and advanced therapy sector today:

  • Advocating for clear, predictable and harmonized regulatory and review pathways
  • Enabling market access and value-based reimbursement policies
  • Addressing industrialization and manufacturing hurdles
  • Conducting key stakeholder outreach, communication and education
  • Facilitating sustainable access to capital and identify sources of potential public funding.

Find Out More

Explore How ARM Leads the Way

ARM is a global community of therapeutic companies small & large, non-profit research institutions, patient organizations, and tool and technology providers. Working with our members and policymakers, we foster investment, research & development, and the successful commercialization of safe and effective treatments and cures for patients around the world.

FIND OUT MORE